A clinical trial to study the effect of ayurvedic drug compound, Nimbashatak Vati in patient with intestinal worm infestation

Clinical study on the management of krimiroga (intestinal worm infestation) in children with Nimbashatak Vati

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/11/010377

Enrollment

Registered

2017-11-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- krimi(intestinal worm infestation)

Interventions

Intervention1: Nimbashatak vati 500mg: child dose as per age will be calculated according to youngs formula. Time of drug administration-at night with luke warm water Control Intervention1: Tab Albend

Eligibility

Inclusion criteria

Inclusion criteria: children with clinical feature of krimiroga and positive stool report for intestinal helminthic infestation (cyst and ova)

Exclusion criteria

Exclusion criteria: patient with major congenital disorders and chronic debilitating disease.

Design outcomes

Primary

Measure	Time frame
Changes in subsidence of the clinical sign and symptoms with negative stool report for ova and cyst.Timepoint: 28 days in both intervention and control grroup	—

Secondary

Measure	Time frame
improvement in general health condition and quality of life.Timepoint: After 30 days	—

Countries

India

Contacts

Public ContactMahesh Patel

Parul Institute of Ayurveda

Sunilchangle16@gmail.com9687613916

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026